Updates are available Correction dated 2016-07-07

Click to view Correction: https://doi.org/10.1186/s13023-016-0463-6

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Crossref DOI link: https://doi.org/10.1186/s13023-014-0199-0

Published Online: 2014-12-18

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark